Penny Stock Under Rs 5: Don't Miss Out on the Micro-Cap's Major News!
Penny Stock Under Rs 5: Don't Miss Out on the Micro-Cap's Major News!

Penny Stock Under Rs 5: Don't Miss Out on the Micro-Cap's Major News!

This groundbreaking technology has the potential for eliminating the need for painful injections.

Aniket Gogate Article rating: 3.0

Transgene Biotek Ltd.'s partnership with NiedlFree Technologies has the potential to revolutionize the way people with diabetes manage their condition. Oral insulin delivery could eliminate the need for painful injections and make it easier for people to adhere to their treatment plans. This could lead to improved health outcomes and a better quality of life for millions of people worldwide.

DSIJ MINDSHARE

Multibaggers19-Jul, 2024

Penny Stocks19-Jul, 2024

Multibaggers19-Jul, 2024

Bonus and Spilt Shares19-Jul, 2024

Penny Stocks19-Jul, 2024

Knowledge

General9-Jul, 2024

General9-Jul, 2024

General9-Jul, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR